Discovering Biomarkers within the Genomic Landscape of Renal Cell Carcinoma.
Recent advances in molecular sequencing technology have led to the discovery of numerous biomarkers in renal cell carcinoma (RCC). These biomarkers have the potential to predict clinical outcomes and aid in clinical management decisions. The following commentary is a review of the preliminary data on some of the most promising genetic biomarker candidates.
Department of Urology, Montefiore Medical Center, USA.
Sankin
S
A
Biomarker; Genomics; Renal cell carcinoma